Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 9/2018

Ausgabe 9/2018

Inhaltsverzeichnis ( 16 Artikel )

05.07.2018 | Review | Ausgabe 9/2018

Targeting tumor-associated acidity in cancer immunotherapy

Ruben Lacroix, Elisa A. Rozeman, Marina Kreutz, Kathrin Renner, Christian U. Blank

09.06.2018 | Commentary | Ausgabe 9/2018

Blood cell count indexes as predictors of outcomes in advanced non-small-cell lung cancer patients treated with Nivolumab

Carlo Putzu, Diego Luigi Cortinovis, Francesca Colonese, Stefania Canova, Ciriaco Carru, Angelo Zinellu, Panagiotis Paliogiannis

02.07.2018 | Original Article | Ausgabe 9/2018

mTOR-mediated glycolysis contributes to the enhanced suppressive function of murine tumor-infiltrating monocytic myeloid-derived suppressor cells

Yuting Deng, Jiao Yang, Feifei Luo, Jing Qian, Ronghua Liu, Dan Zhang, Hongxiu Yu, Yiwei Chu

02.07.2018 | Original Article | Ausgabe 9/2018

Peripheral monocytes and neutrophils predict response to immune checkpoint inhibitors in patients with metastatic non-small cell lung cancer

Kaushal Parikh, Arun Kumar, Jibran Ahmed, Asad Anwar, Carmelo Puccio, Hoo Chun, Michael Fanucchi, Seah H. Lim

03.07.2018 | Original Article | Ausgabe 9/2018

Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette–Guerin for patients with non-muscle invasive bladder cancer

Wataru Obara, Isao Hara, Yoichiro Kato, Renpei Kato, Keiji Inoue, Fuminori Sato, Hiromitsu Mimata, Yusuke Nakamura, Tomoaki Fujioka

04.07.2018 | Original Article | Ausgabe 9/2018

Potentiation of PD-L1 blockade with a potency-matched dual cytokine–antibody fusion protein leads to cancer eradication in BALB/c-derived tumors but not in other mouse strains

Roberto De Luca, Dario Neri

04.07.2018 | Original Article | Ausgabe 9/2018

Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer

Lourdes Barrera, Edgar Montes-Servín, Juan-Manuel Hernandez-Martinez, Mario Orozco-Morales, Elizabeth Montes-Servín, David Michel-Tello, Renato Augusto Morales-Flores, Diana Flores-Estrada, Oscar Arrieta

05.07.2018 | Original Article | Ausgabe 9/2018

Anti-ADAM17 monoclonal antibody MEDI3622 increases IFNγ production by human NK cells in the presence of antibody-bound tumor cells

Hemant K. Mishra, Nabendu Pore, Emil F. Michelotti, Bruce Walcheck

11.07.2018 | Original Article | Ausgabe 9/2018

Fulminant onset of insulin-dependent diabetes with positive anti-GAD antibody titers during treatment with nivolumab in a patient with NSCLC

Nobuko Matsuura, Genju Koh, Chihiro Konishi, Satoshi Minamino, Yoshinori Takahara, Hiromasa Harada, Ken Kodama, Masanori Emoto

13.07.2018 | Original Article | Ausgabe 9/2018 Open Access

Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells

Annette E. Sköld, Till S. M. Mathan, Jasper J. P. van Beek, Georgina Flórez-Grau, Michelle D. van den Beukel, Simone P. Sittig, Florian Wimmers, Ghaith Bakdash, Gerty Schreibelt, I. Jolanda M. de Vries

20.07.2018 | Original Article | Ausgabe 9/2018

Production of a mouse monoclonal IgM antibody that targets the carbohydrate Thomsen-nouveau cancer antigen resulting in in vivo and in vitro tumor killing

Kevin R. Trabbic, Kristopher A. Kleski, Mengchao Shi, Jean-Paul Bourgault, Jillian M. Prendergast, Daniel T. Dransfield, Peter R. Andreana

20.07.2018 | Original Article | Ausgabe 9/2018 Open Access

CD11c+ MHCIIlo GM-CSF-bone marrow-derived dendritic cells act as antigen donor cells and as antigen presenting cells in neoepitope-elicited tumor immunity against a mouse fibrosarcoma

Hakimeh Ebrahimi-Nik, William L. Corwin, Tatiana Shcheglova, Alok Das Mohapatra, Ion I. Mandoiu, Pramod K. Srivastava

16.07.2018 | Clinical Trial Report | Ausgabe 9/2018

Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma

Tessa Gargett, M. Nazim Abbas, Paul Rolan, Jason D. Price, Katharine M. Gosling, Antonio Ferrante, Andrew Ruszkiewicz, Ines I. C. Atmosukarto, Joseph Altin, Christopher R. Parish, Michael P. Brown

18.07.2018 | Letter to the Editors | Ausgabe 9/2018

“Pseudoprogression”: more than semantics

Janice P. Dutcher

30.07.2018 | Letter to the Editors | Ausgabe 9/2018

Reply to “Pseudoprogression”: more than semantics

Alvin S. Wong, Martin B. Lee

06.08.2018 | Correction | Ausgabe 9/2018

Correction to: High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer

Yusuke Okuma, Tsunekazu Hishima, Jumpei Kashima, Sadamu Homma

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise